Programme and Presentations

UK & Ireland Prostate Brachytherapy Conference 2016

Friday 13th May 2016

The Roxburghe Hotel, Edinburgh

    ABSTRACT SLIDES  
  Presentations      
  An update on LDR Brachytherapy   Alastair Law (Consultant Clinical oncologist, Edinburgh Cancer Centre)
  Treating High Risk Prostate Cancer – Surgery Has The Edge!   Alan McNeill (Department of Urology Lothian University Hospitals)
  PSA nadir post LDR Brachytherapy and early Salvage Therapy   Dr Duncan McLaren (Edinburgh)
  High Dose Rate Brachytherapy 2014 – 2016   John Logue (Manchester)
  Is ASCENDE-RT still pertinent? Is LDR-PB obsolete?   W. James Morris (Vancouver)
  Functional radiotherapy targeting using focused dose escalation   Roberto Alonzi (Mount Vernon Cancer Centre)
  SABR (SBRT) for Prostate Cancer   Suneil Jain (Queen’s University Belfast)
  Physics Technology Update   William Keough (Edinburgh Cancer Centre)
  Oral & Poster Presentations      
  Physics Abstracts      
  MRI based pre-planning method for I-125 seed “one-step” implantation   Inchley D
  The effect of calcifications on prostate brachytherapy   Lee J
  Monte Carlo in the assessment of the effects of tissue composition on dose distributions in low dose rate prostate brachytherapy   Leydon P
  Global and sector based dosimetric comparison of plugged vs plug-free needles in permanent prostate brachytherapy   Sarri L
  Clinical Abstracts      
  Training for care of prostate brachytherapy patients   Wang Y
 

Predictors of survival and causes of death following low-dose rate brachytherapy and robotic-assisted laparoscopic prostatectomy in low- and intermediaterisk prostate cancer: a UK Cancer Registry-linked study

  Yamamoto H
  Poster Presentations      
  Physics Abstracts      
  Review of the dosimetry of a nine year 125-Iodine seeds prostate brachytherapy programme   Kleefeld C
  Clinical Abstracts      
  A single centre analysis of change in dosimetric outcomes through implementing a 1-Stage intraoperative implant technique   Keating F
  Long-term biochemical control and morbidity outcomes with HDR prostate brachytherapy boost in combination with external beam radiotherapy   Teo M

< back to archive